Metraipolis › archive › dc_a86aa350b429

EDL6D, a bioactive peptide phenocopying SHBG-associated metabolic effects: a new preclinical lead compound for treating the metabolic dysfunction-associated… — Europe PMC PMID:42143387

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42143387
DOI
10.1186/s12967-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-02T06:02:15.875Z
SHA-256 of the archived text
0b23b69f0107bbc2be24cc12685c9581b785393e6142ca09411568d1b008445f
Stable URL of this page
https://metraipolis.com/documento/dc_a86aa350b429

How to cite

EDL6D, a bioactive peptide phenocopying SHBG-associated metabolic effects: a new preclinical lead compound for treating the metabolic dysfunction-associated… — Europe PMC PMID:42143387 — Europe PMC (en), https://europepmc.org/article/MED/42143387 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a86aa350b429 (Metraipolis archive dc_a86aa350b429, sha256 0b23b69f0107bbc2be24cc12685c9581b785393e6142ca09411568d1b008445f)
BibTeX
@misc{dca86aa350b429,
  title = {EDL6D, a bioactive peptide phenocopying SHBG-associated metabolic effects: a new preclinical lead compound for treating the metabolic dysfunction-associated… — Europe PMC PMID:42143387},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42143387},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a86aa350b429; sha256 0b23b69f0107bbc2be24cc12685c9581b785393e6142ca09411568d1b008445f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42143387. Agents can read the archived copy with the MCP tool read_document.